We’re excited to announce that we’re co-leading a $28M Seed round in Boltz PBC. @boltz_bio comes out of research at MIT from Gabriele Corso, Jeremy Wohlwend, and Saro Passaro. They’ve built frontier open-source AI models for biomolecular research that saw explosive growth in usage among scientists, which is especially impressive for a project out of academia. Their models have been used by over 100,000 scientists, every top 20 pharma company, and thousands of biotechs. Now, the team is going all in on scaling their proven ability to develop cutting edge models with the infrastructure and product sense to make them usable in the lab. Their Boltz Lab platform provides deployment-ready infrastructure that integrates models with proprietary generative AI workflows, intuitive user interfaces and high-performance compute. Boltz Lab is now available and is already being used by partners like @pfizer. By @JorgeCondeBio and @zakdoric @GabriCorso @jeremyWohlwend(a16z)